0000000000459779

AUTHOR

K. Geboes

showing 2 related works from this author

1381P Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month…

2021

Oncologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCheckmateCancerHematologymedicine.diseaseGastroesophageal JunctionOncologyInternal medicineMedicineNivolumabbusinessAdjuvantNeoadjuvant chemoradiotherapyMonth follow upAnnals of Oncology
researchProduct

LBA9_PR Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiation therapy (CRT): F…

2020

Oncologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCheckmateCancerHematologymedicine.diseaseGastroesophageal JunctionOncologyInternal medicinemedicineNivolumabbusinessAdjuvantAnnals of Oncology
researchProduct